Tumor hypoxia and systemic levels of vascular endothelial growth factor (VEGF) in head and neck cancers

Strahlentherapie und Onkologie

Volumn 177, Issue 9, 2001, Pages 469-473

  Dunst, Jürgen ^a   Stadler, Peter ^b   Becker, Axel ^a   Kuhnt, Thomas ^a   Lautenschläger, Christine ^a   Molls, Michael ^b   Haensgen, Gabriele ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Angiogenesis; Head and neck cancer; Hypoxia

Indexed keywords

HEMOGLOBIN; VASCULOTROPIN;

ADULT; AGED; ANEMIA; ANGIOGENESIS; ARTICLE; BLOOD LEVEL; HEAD AND NECK CANCER; HUMAN; HYPOXEMIA; MAJOR CLINICAL STUDY; THROMBOCYTE COUNT; TISSUE OXYGENATION; TUMOR VOLUME;

EID: 0034832179     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00002428     Document Type: Article

References (36)

1. Release of the angiogenetic cytocine vascular endothelial growth factor (VEGF) from platelets: Significance for VEGF measurements and cancer biology
2. Severe anemia is associated with poor tumor oxygenation in head and neck squarnous cell carcinoma
3. Vascular endothelial growth factor (VEGF) mRNA expression in human tumor models of different histologies
4. A quantitative analysis of the reduction in oxygen levels required to induce up-regulation of vascular endothelial growth factor (VEGF) mRNA in cervical cancer lines
5. Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis
6. Serum basic fibroblast growth factor and vascular endothelial growth factor and tumour growth kinetics in advanced colorectal cancer
7. Low hemoglobin is associated with increased serum levels of vascular endothelial growth factor (VEGF) in cancer patients. Does anemia stimulate angiogenesis?
8. Clinical implications of research on angiogenesis
9. Cervix cancer oxygenation measured following external radiation therapy
10. Comparative evaluation of angiogenesis assessment with anti-factor-VIII and anti-CD31 immunostaining in non-small cell lung cancer
11. Significance of hemoglobin concentrations for treatment outcome
12. The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix
13. Thrombocytes are the major source for soluble vascular endothelial growth factor in the peripheral blood
14. 2 predicts survival in advanced cancer of the uterine cervix
15. Serum vascular endothelial growth factor in patients with head and neck squamous cell carcinoma
16. Pitfalls in the measurement of circulating vascular endothelial growth factor
17. Circulating vascular endothelial growth factor (VEGF) is a possible tumor marker for metastasis in hepatocellular carcinoma
18. 2-measurements as predictive assay in the treatment of carcinoma of the uterine cervix
19. Vascular endothelial growth factor/vascular permeability factor is detectable in the sera of tumor-bearing mice and cancer patients
20. Vascular endothelial growth factor is a secreted angiogenic mitogen
21. Vascular endothelial growth factor is of high prognostic value in node-negative breast carcinoma
22. Correlation of vascular endothelial growth factor content with recurrences, survival and first relapse site in primary node-positive breast carcinoma
23. In vitro release of vascular endothelial growth factor during platelet aggregation
24. Measurements of the human tumor oxygenation status by polarographic needle electrode
25. A confirmative study on oxygenation status and locoregional control in advanced head and neck squamous cell carcinomas treated by radiation therapy
26. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo
27. A high pretreatment serum vascular endothelial growth factor concentration is associated with poor outcome in non-Hodgkin's lymphoma
28. Serum vascular endothelial growth factor is often elevated in disseminated cancer
29. Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor
30. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
31. Influence of the hypoxic subvolume on the survival of patients with head and neck cancer
32. Oxygenation of human tumors
33. Platelets: Transporter of vascular endothelial growth factor
34. Tumor angiogenesis and metastasis: Correlation in invasive breast carcinoma
35. Large amounts of vascular endothelial growth factor at the site of hemostatic plug formation in vivo
36. Concentration of vascular endothelial growth factor in the sera of normal controls and cancer patients